Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HCFA Makes Public Near-Final Coverage Decisions On Three Devices

This article was originally published in The Gray Sheet

Executive Summary

The first evidence of a more open Medicare coverage process appeared on the Health Care Financing Administration's web site Feb. 3, as the agency posted coverage information for four devices: cardiac monitoring by electrical bioimpedance, external counterpulsation, transmyocardial revascularization, and positron emission tomography.

You may also be interested in...



Electrical bioimpedance for hypertension NCD

Thoracic electrical bioimpedance (TEB) for treating drug-resistant hypertension is left to local carrier discretion, CMS states in an 1Aug. 7 national coverage determination decision memo. On the same day, the agency issued a national non-coverage policy for TEB in managing all other forms of hypertension. Six indications of TEB are already covered under an NCD (2"The Gray Sheet" Feb. 8, 1999, p. 7). CardioDynamics offers the BioZ impedance cardiography (ICG) test...

Big Pharma BD Execs Tell Start-Ups: Don’t Be Afraid To Ask Us For Help

Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.

UsernamePublicRestriction

Register

MT011293

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel